Search Results - "McDunn, Jon"

Leveraging external data in the design and analysis of clinical trials in neuro-oncology by Rahman, Rifaquat, Ventz, Steffen, McDunn, Jon, Louv, Bill, Reyes-Rivera, Irmarie, Polley, Mei-Yin C, Merchant, Fahar, Abrey, Lauren E, Allen, Joshua E, Aguilar, Laura K, Aguilar-Cordova, Estuardo, Arons, David, Tanner, Kirk, Bagley, Stephen, Khasraw, Mustafa, Cloughesy, Timothy, Wen, Patrick Y, Alexander, Brian M, Trippa, Lorenzo

“…Integration of external control data, with patient-level information, in clinical trials has the potential to accelerate the development of new treatments in…”
Get full text

Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy by Chen, Steven T, Semenov, Yevgeniy R, Alloo, Allireza, Bach, Daniel Q, Betof Warner, Allison, Bougrine, Amina, Burton, Leeann, Cappelli, Laura C, Castells, Mariana, Cohen, Justine, Dewan, Anna K, Fadden, Riley, Guggina, Lauren, Hegde, Aparna, Huang, Victor, Johnson, Douglas B, Kaffenberger, Benjamin, Kroshinsky, Daniela, Kwatra, Shawn, Kwong, Bernice, Lacouture, Mario E, Larocca, Cecilia, Leventhal, Jonathan, Markova, Alina, McDunn, Jon, Mooradian, Meghan J, Naidoo, Jarushka, Choi, Jennifer, Nambudiri, Vinod, Nelson, Caroline A, Patel, Anisha B, Pimkina, Julia, Rine, Johnathan, Rubin, Krista M, Sauder, Maxwell, Shaigany, Sheila, Shariff, Afreen, Sullivan, Ryan J, Zubiri, Leyre, Reynolds, Kerry L, LeBoeuf, Nicole R

“…With an increasing number of patients eligible for immune checkpoint inhibitors, the incidence of immune-related adverse events (irAEs) is on the rise…”
Get full text

Comparison of survival outcomes of patients with newly diagnosed glioblastoma treated with standard chemoradiation in and outside of clinical trials by Rahman, Rifaquat, Youssef, Gilbert, Ventz, Steffen, Redd, Robert, McDunn, Jon, Louv, William, Alexander, Brian Michael, Wen, Patrick Y., Trippa, Lorenzo

“…2051 Background: Randomized clinical trials use stringent eligibility criteria to select patients which can raise concerns about generalizability of study…”
Get full text

KMDATA: a curated database of reconstructed individual patient-level data from 153 oncology clinical trials by Fell, Geoffrey, Redd, Robert A, Vanderbeek, Alyssa M, Rahman, Rifaquat, Louv, Bill, McDunn, Jon, Arfè, Andrea, Alexander, Brian M, Ventz, Steffen, Trippa, Lorenzo

“…Abstract We created a database of reconstructed patient-level data from published clinical trials that includes multiple time-to-event outcomes such as overall…”
Get full text